{"schema_version":1,"assessment_id":"eoa_inverse_innovation_exp03_opportunity320_20260801","source_experiment_id":"eoa_inverse_innovation_exp03_full320_20260801","cell_id":"layer_decay_and_expiration_management__medicine_healthcare","archetype_slug":"layer_decay_and_expiration_management","domain_slug":"medicine_healthcare","title":"Lifecycle-State-Gated Clinical Content Activation","opportunity_summary":"Evaluate a governed lifecycle system that inventories versioned clinical content, routes suspected stale artifacts for human review, deactivates superseded versions from ordinary selection, preserves governed historical access, and verifies restoration before authorized destruction. The clinical-risk mechanism is plausible, but problem prevalence, operating benefit, and distinctiveness remain unverified.","adopter_authorizer":"A hospital clinical-content governance body would adopt and authorize activation or retirement workflows, with health-informatics and EHR administrators implementing them and records, privacy, and legal officers retaining authority over holds, retention, and destruction.","scores":{"meaningful_impact":{"score":4,"rationale":"If obsolete order sets, alerts, protocols, or reference content are selectable, separating current clinical authority from historical retention could reduce outdated-guidance exposure while preserving incident reconstruction. The packet does not establish how often this condition occurs or the realized effect size."},"stakeholder_pull":{"score":3,"rationale":"Clinicians, content owners, informatics administrators, patient-safety staff, and records or legal personnel have recognizable interests in unambiguous current guidance and recoverable history, but the sealed candidate contains no evidence of demand, budget commitment, or adoption requests."},"incremental_advantage":{"score":4,"rationale":"Relative to ticket-and-spreadsheet review and mandatory recertification alone, the proposal adds integrated lifecycle states, dependency tracing, holds, reversible quarantine, restoration testing, and exception governance. Whether these additions improve accuracy or disposition speed is untested."},"distinctiveness_plausibility":{"score":2,"rationale":"The particular composition is coherent, but the candidate explicitly labels prior art as unsearched and supplies no comparison with existing EHR functions, governance standards, or lifecycle implementations; distinctiveness therefore cannot be credited beyond plausibility."},"technical_implementability":{"score":3,"rationale":"Inventorying versions, recording states, generating candidates, and simulating dispositions appear technically tractable, but reliable identity resolution, dependency discovery, production gating, archival fidelity, and external-consumer detection may be difficult across heterogeneous clinical systems."},"adoption_authority_feasibility":{"score":4,"rationale":"The proposal identifies separate clinical-governance and records, privacy, and legal authorities, prohibits automation from validating guidance or overriding holds, and bounds a non-production pilot. Cross-functional coordination and divided mandates still create adoption friction."},"evidence_readiness":{"score":3,"rationale":"A 12-week shadow pilot with at most 50 non-emergency order sets, baseline comparisons, explicit falsifiers, restoration checks, and halt conditions is specified. Readiness is limited because the reference standard, blinded adjudication process, denominators, and acceptance thresholds are not fully prespecified."},"safety_net_benefit":{"score":4,"rationale":"Quarantine, audit evidence, governed restoration, explicit holds, prohibition of permanent pilot deletion, and rollback on misclassification or missed dependencies provide meaningful protection against both stale use and premature loss. Restore fidelity and dependency coverage remain unproven."},"scalability":{"score":3,"rationale":"The lifecycle-state model could extend across order sets, alerts, protocols, and reference artifacts, but scaling would require system-specific integrations, ownership resolution, recurring clinical review, retention-policy mapping, and validation of dependencies in each environment."}},"score_confidence":"MODERATE","costs":{"first_evidence":{"band_2026_usd":"50K_TO_250K","scope":"Design and execute the specified 12-week shadow pilot for one service line and no more than 50 non-emergency order sets, including inventory, adjudication, dependency tracing, simulated dispositions, sampled restoration, privacy review, and evaluation.","confidence":"MODERATE","assumptions":["Existing EHR exports or administrative interfaces provide usable artifact metadata.","No production activation, permanent deletion, or patient-facing workflow change occurs.","A multidisciplinary clinical, informatics, records, legal, privacy, and evaluation team contributes part-time labor.","The pilot must define an independent adjudication reference standard and baseline comparison before analysis."]},"initial_deployment_startup":{"band_2026_usd":"250K_TO_1M","scope":"Prepare a limited production-capable deployment after successful evidence, including integrations, lifecycle metadata, role and approval controls, archive and rollback procedures, dependency validation, training, security review, and governance configuration.","confidence":"LOW","assumptions":["Deployment is limited to one hospital or a small set of service lines.","The existing EHR supports needed interfaces without major vendor redevelopment.","Historical artifacts can be mapped without extensive manual reconstruction.","Clinical activation and destruction remain human-authorized."]},"operational_launch":{"band_2026_usd":"1M_TO_5M","scope":"Launch across a hospital enterprise or comparable multi-service environment, covering content migration, workflow integration, dependency mapping, retention and hold controls, validation, training, change management, restore testing, and monitored rollout.","confidence":"LOW","assumptions":["The institution has multiple clinical-content classes and substantial legacy version history.","Enterprise launch requires vendor and compliance coordination plus phased validation.","The band excludes replacement of the core EHR or creation of a new enterprise archive.","No prevalence, institution size, or integration-complexity evidence is supplied."]},"annual_recurring":{"band_2026_usd":"250K_TO_1M","scope":"Operate lifecycle governance after launch, including clinical recertification and disposition review, content ownership administration, monitoring, audit support, archive maintenance, restore drills, training, software support, and policy updates.","confidence":"LOW","assumptions":["Recurring work is performed by a cross-functional team rather than a fully autonomous system.","Review volume is bounded by configured expiry events and risk-based triage.","Major EHR replacement, litigation-scale discovery, and exceptional remediation are excluded.","Actual artifact volume and staffing requirements are unknown."]}},"research_burden":"HIGH","earliest_credible_horizon":"3_TO_12_MONTHS","pipeline_gates":{"recognizable_externally_supportable_problem":{"status":"YES","reason":"The candidate describes an independently recognizable failure mode: obsolete clinical content may remain active or misleadingly discoverable while indiscriminate deletion can impair reconstruction. External prevalence and magnitude still require measurement."},"identifiable_adopter_or_authorizer":{"status":"YES","reason":"A designated clinical-content governance body is identified for activation and retirement, with records, privacy, and legal officers controlling retention, holds, and destruction within their mandates."},"distinct_testable_incremental_claim":{"status":"YES","reason":"Against ordinary ticket or spreadsheet review, the proposal can test whether integrated lifecycle governance improves correct stale-candidate identification and time-to-owner disposition while preserving dependency detection and archive restoration."},"bounded_next_evidence_step":{"status":"YES","reason":"The sealed candidate specifies a 12-week shadow pilot on one service line and at most 50 non-emergency order sets, with no patient-facing activation or permanent deletion and with explicit comparison outcomes and falsifiers."},"no_unresolved_safety_or_authority_stop":{"status":"YES","reason":"The pilot preserves human clinical and legal authority, excludes autonomous destruction and production activation, and mandates halt and rollback for misclassification, missed dependencies, disclosure, restoration failure, or production leakage. These controls make shadow evaluation permissible despite unresolved performance evidence."},"implementation_cost_scope_and_range":{"status":"YES","reason":"The proposed pilot and subsequent deployment stages are bounded sufficiently to assign broad resource-equivalent bands, although institution size, EHR interfaces, artifact volume, and integration complexity make the ranges low-confidence."}},"blocking_evidence":["A scoped audit must establish whether obsolete artifacts are active or misleadingly discoverable rather than merely retained as hidden required history.","The pilot needs a prespecified independent clinical-governance reference standard, disagreement resolution process, denominators, and acceptance thresholds.","Dependency discovery must be tested for external, runtime, and undocumented consumers; any missed live dependency is a safety-critical failure.","Sampled quarantine and archive restoration must demonstrate 100% fidelity under the specified pilot gate.","Existing governance standards, EHR capabilities, and comparable lifecycle implementations must be researched before any distinctiveness claim.","Adopter interviews must establish whether the proposed gains justify recurring multidisciplinary review and integration burden."],"next_evidence_step":"Run the authorized 12-week shadow pilot on one service line and no more than 50 non-emergency order sets after prespecifying blinded governance adjudication. Compare the proposed lifecycle workflow with ordinary ticket-and-spreadsheet practice on correctly identified stale artifacts and time-to-owner disposition, while testing every sampled archive for restoration fidelity. Falsify progression if there is no improvement on the prespecified primary outcome, any current-content misclassification or missed live dependency occurs, or sampled restoration is below 100%; permit no production activation or permanent deletion.","research_questions":["Does a scoped inventory find obsolete content that is active or misleadingly discoverable, and can users actually encounter it?","What independent adjudication standard reliably distinguishes clinically current, superseded, archived, held, quarantined, and destroyable content?","Does lifecycle governance improve stale-candidate precision and time-to-owner disposition relative to ordinary review without increasing unsafe classifications?","Can dependency tracing detect external, runtime, and undocumented consumers with sufficient reliability?","Can quarantined and archived artifacts be restored with complete content, metadata, provenance, and access-control fidelity?","How much multidisciplinary review workload does the system create, and do reviewers develop superficial attestation behavior?","Which retention, privacy, legal-hold, and destruction rules conflict across artifact classes or jurisdictions?","What existing standards, vendor functions, or implementations already provide some or all of the proposed mechanism composition?","Which integration and governance costs recur when extending from one service line to enterprise scale?","Do clinicians and governance authorities consider the measured improvement sufficient to authorize and resource adoption?"] ,"recommendation":"PRIOR_ART_RESEARCH","uncertainty_constraints":["Problem prevalence and the frequency of clinician exposure to stale selectable content are unsupported.","Clinical or operational effect size is hypothetical.","Prior-art status, world novelty, and distinctiveness are unmeasured.","Market size, purchasing demand, and budget ownership are unmeasured.","Exact integration complexity, artifact volume, staffing burden, and cost are unknown.","Clinical validity does not decay monotonically with age, and rare use cannot safely serve as a proxy for low value.","Dependency detection and restoration performance have not been demonstrated.","The proposed cost bands are resource-equivalent planning ranges, not observed prices or estimates from external sources."],"closed_book_prior_art_boundary":"Prior art was not searched and remains unverified in this closed-book assessment; no claim is made that the proposal, its components, or their composition is novel or absent from existing standards, EHR products, governance programs, patents, or implementations."}